Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR.

Clinical chemistry - 1 May 2003

Erali Maria, Schmidt Ben, Lyon Elaine, Wittwer Carl

Abstract excerpt

BACKGROUND: Genetic risk factors associated with venous thrombosis include mutations in the factor V (Leiden), factor II (prothrombin), and methylenetetrahydrofolate reductase (MTHFR) genes. We evaluated a method using electronically addressable microarrays for the detection of mutations in these genes that have been associated with vascular disease. METHODS: The NanoChip Molecular Biology Workstation (Nanogen)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Genotype
Share to Methylenetetrahydrofolate Reductase (NADPH2)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Oligonucleotide Array Sequence Analysis

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Polymerase Chain Reaction

Share to Prothrombin

Source

Identifiers

PMID: 12709363
DOI: 10.1373/49.5.732

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR.PMID 12709363Read ↗

Diagnostic single nucleotide polymorphism analysis of factor V Leiden and prothrombin 20210G > A. A comparison of the Nanogen Eelectronic Microarray with restriction enzyme digestion and the Roche LightCycler.Semantic proximity Read ↗

Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology.Semantic proximity Read ↗

Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip 400 and molecular biology workstation.Semantic proximity Read ↗

An improved electronic microarray-based diagnostic assay for identification of MEFV mutations.Semantic proximity Read ↗

Determination of the factor V Leiden single-nucleotide polymorphism in a commercial clinical laboratory by use of NanoChip microelectronic array technology.Semantic proximity Read ↗

Microarray-based genetic analyses for studying susceptibility to arterial and venous thrombotic disorders.Semantic proximity Read ↗

Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation.Semantic proximity Read ↗

Evaluation of the Nanosphere Verigene System and the Verigene F5/F2/MTHFR Nucleic Acid Tests.Semantic proximity Read ↗

A microplate allele-specific oligonucleotide hybridization assay for detection of factor V Leiden.Semantic proximity Read ↗

Multiple sample amplification and genotyping integrated on a single electronic microarray.Semantic proximity Read ↗

Single-nucleotide polymorphism and mutation identification by the nanogen microelectronic chip technology.Semantic proximity Read ↗

Analysis of LDLR mutations in familial hypercholesterolemia patients in Greece by use of the NanoChip microelectronic array technology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.